Description: Join us for a discussion of the supplemental health landscape for accident, critical illness, STD, and hospital indemnity products. This session will include both the pricing actuary and the regulator perspectives on new approaches, trends, renewal rate strategies, the competitive market, state-specific requirements, and more!!Attendees will learn about changes in the market that will help them price products, evaluate new approaches used in the voluntary market, and identify the issues that will make their products successful.

Description: Over the course of ImpAct conference, we have taken you on a journey to understand the impact of climate change to the insurance industry. We have examined the risks to the industry both on a short and long term. We looked at tools and approaches, both on the liability and asset sides, to address this emerging risk. Evidences have shown, not only the need to incorporate climate risks is pressing, as an industry, we shall recognize the responsibilities to lead the evolution. This session aims to put everything together and explore progress on company's enterprise risk management (ERM) process to incorporate climate risks and enterprises' attempt to provide sustainability information to audiences in need. We will discuss the latest development in international standard on sustainability disclosure. We will diagnose the challenges on implementation and effort to resolve them. We will compare the requirements and latest developments across different jurisdictions and possible cross learning among them. To conclude, we will land on what opportunities are available to the actuarial community! At the end of this session, participants will be able to: - Discover requirements on sustainability reporting standards across different jurisdictions - Appreciate the challenges and progress to integrate climate risks in company's ERM approaches - Comprehend actuaries' opportunities and responsibilities to contribute

Description: Artificial intelligence (AI) presents numerous opportunities in the insurance and financial industries. It also comes with heightened model, operational, legal and compliance, financial, and data risk. In this session, we will discuss speculation that emerging AI capabilities have sparked the fourth industrial revolution, examine what is different about this most recent round of capabilities, and examine why industry experts warn about the heightened risks the use of AI presents. We will review a framework - which includes AI ethical principles, standards, and best practices - to govern the use of AI. This will include a cross-reference of relevant Actuarial Standards of Practice as well as industry guidance like the NAIC Model Bulletin on the Use of AI Systems by Insurers. This framework will help actuaries and insurance professionals gain confidence that - if governed appropriately - we can reap the vast rewards of using AI systems in our industry.

Description: Pre-eminent healthcare actuaries and policy experts present their pitch for how they'd fix US healthcare (whatever they think 'fix' means) if they were supreme policy maker for a day. No idea is too big, and no policy dream is too small! Each candidate will have only a short time to win the audience's approval and will need to survive a grilling after the pitch. The audience will vote on the winner, who will be crowned 'ImpAct Meeting Healthcare Policy Wonk' for 2024!

Description: Listen to pre-eminent healthcare actuaries present their pitch for how they'd fix US healthcare (whatever the pitch thinks 'fix' means) if they were supreme policy maker for a day. No idea is too big, and no healthcare actuary's dream is too small.

Description: Attendees will learn what the Health Equity Index is, how it will be calculated, how it affects quality and Star metrics for Medicare Advantage plans, and how this could change the industry as a whole moving forward.

Description: The Inflation Reduction Act represents the most significant changes to the Part D program since its inception 20 years ago. The implications will not only alter the benefits offered by Medicare Advantage (MAPD) and Prescription Drug Plans (PDP) but will alter the Part D cash flows and the seasonality of such amounts for interim reporting periods. In this session, we will provide a brief overview of the IRA changes and dive into how the changes could impact the 2008 Medicare Part D Accounting Practice Note.

Description: "Spread pricing is a pricing methodology where pharmacy benefit managers (PBMs) bill a payer one price but reimburses the dispensing pharmacy a lower price for the same prescription drug. PBMs have historically relied on spread pricing as a revenue source. However, a growing number of states are introducing and passing legislation prohibiting spread pricing for Medicaid and commercial clients. In addition, new entrants to the PBM and mail-order pharmacy space are disrupting the market by offering services that promote increased transparency and member satisfaction. Expect updates on recent legislative trends and market disruptions targeted towards increasing PBM drug pricing transparency. By attending this session, you will have a better understanding of how changing legislation and market disruptions may impact current pricing methodologies."

Description: Discover an update on recent developments affecting U.S. retirement plans, such as regulatory guidance, new legislative proposals, recent court cases and recent trends. Experienced pension actuaries will share their perspectives on these issues and the impact on plan sponsors.

Description: Join us for an insightful webcast as we delve into the far-reaching implications of the recent Supreme Court decision to overturn Chevron deference. This landmark ruling, which previously granted federal agencies significant leeway in interpreting ambiguous statutes, is set to reshape the landscape of healthcare policy.